Tempus, a technology company leading the adoption of AI to advance precision medicine, today highlighted results of the Articulate Pro study, published in Nature Digital Medicine, evaluating the use ...
Tempus AI Inc (NASDAQ:TEM) reported fourth-quarter financial results after the market close on Monday. Here’s a look at the key metrics from the quarter. Q4 Earnings: Tempus AI reported fourth-quarter ...
ESA is working with Argentina to test telemedicine device Tempus Pro in the harsh conditions of Antarctica as Europe prepares for its next phase of human exploration in space. The development of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results